Duloxetine Dr 30 &Amp, 60 Teva 30mg. 60mg Capsule
PDF Leaflet Revision Date: 11 December 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression and diabetic peripheral neuropathic pain.
Dosage (summary)
60 mg once daily for adults; 30 mg once daily for mild to moderate renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation due to safety concerns.
Key Drug Interactions
- MAOIs
- CYP1A2 inhibitors
- CYP2D6 inhibitors
- Serotonergic medicines
Contraindications
- Hypersensitivity to duloxetine
- Severe hepatic impairment
- Uncontrolled hypertension
Common side effects
- Nausea
- Headache
- Dry mouth
- Somnolence
- Dizziness
Counselling Points
- Monitor for suicidal thoughts
- Avoid abrupt discontinuation
- Caution with driving if sedated
Serious warnings
- Risk of serotonin syndrome
- Increased blood pressure
- Suicidal ideation
Important Disclaimer
The Duloxetine Dr 30 &Amp, 60 Teva 30mg. 60mg Capsule professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
